Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.

AMA supports reimbursement for pharmacologic stress agent regadenoson
The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.
FDA posts guidance on managing risk of drug shortages
The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.
Statin reduces risk for non-obstructive CAD patients but no significant risk reduction for aspirin
The results of a study published in Radiology: Cardiothoracic Imaging call into question the value of initiating aspirin therapy in certain instances.

The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting. #AMA #AMA175 #AMAmtg #ASNC

AMA supports reimbursement for pharmacologic stress agent regadenoson

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

June 22, 2022

FDA posts guidance on managing risk of drug shortages

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

May 24, 2022

Statin reduces risk for non-obstructive CAD patients but no significant risk reduction for aspirin

The results of a study published in Radiology: Cardiothoracic Imaging call into question the value of initiating aspirin therapy in certain instances.

April 29, 2022

Around the web

Cardiovascular Business

Medicare drops AUC requirement for advanced imaging, ASNC celebrates

"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.

Cardiovascular Business

Cardiology, radiology groups urge insurance provider to rethink imaging policy

SCAI and four other major healthcare organizations signed a joint letter in support of intravascular ultrasound.

Cardiovascular Business

Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.